Iuliia Gracheva

Ms. Iuliia Gracheva

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2020 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
IGIuliia Gracheva
Iuliia Gracheva
ESEkaterina Sergeevna Shchegravina
Ekaterina Sergeevna Shchegravina
HSHans-Guenther Schmalz
Hans-Guenther Schmalz
IBIrina P. Beletskaya
Irina P. Beletskaya
Alexey Yu. FedorovAlexey Yu. Fedorov
Alexey Yu. Fedorov

1 December 2017 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ESEkaterina S. Shchegravina
Ekaterina S. Shchegravina
AMAlexander A. Maleev
Alexander A. Maleev
SIStanislav K. Ignatov
Stanislav K. Ignatov
IGIuliia Gracheva
Iuliia Gracheva
ASAndreas Stein
Andreas Stein
Alexey Yu. FedorovAlexey Yu. Fedorov
Alexey Yu. Fedorov

1 January 2017 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
IGIuliia Gracheva
Iuliia Gracheva
IVIuliia V. Voitovich
Iuliia V. Voitovich
VFVladimir I. Faerman
Vladimir I. Faerman
NSNikolay S. Sitnikov
Nikolay S. Sitnikov
EMEkaterina V. Myrsikova
Ekaterina V. Myrsikova
Alexey Yu. FedorovAlexey Yu. Fedorov
Alexey Yu. Fedorov

1 February 2017 in Chemistry of Heterocyclic Compounds
Verified
Journal Article
Closed access
PDF file
AGArthur A. Grigor’eV
Arthur A. Grigor’eV
SKSergey V. Karpov
Sergey V. Karpov
YKYakov S. Kayukov
Yakov S. Kayukov
ONOleg Evgenievich Nasakin
Oleg Evgenievich Nasakin
IGIuliia Gracheva
Iuliia Gracheva
VTVictor A. Tafeenko
Victor A. Tafeenko

28 May 2018 in Synthesis
Verified
Journal Article
Closed access
PDF file
Alexey Yu. FedorovAlexey Yu. Fedorov
Alexey Yu. Fedorov
IGIuliia Gracheva
Iuliia Gracheva
ESElena V. Svirshchevskaya
Elena V. Svirshchevskaya
VFVladimir I. Faerman
Vladimir I. Faerman
Irina Petrovna  BeletskayaIrina Petrovna Beletskaya
Irina Petrovna Beletskaya
Based on the natural antimitotic agent colchifoline as a lead structure, a series of novel bifunctional allocolchicine congeners were synthesized from commercial colchicine. The new derivatives maintain good cytotoxicity against T3M4, MiaPaCa-2, and PANC-1 cell lines. The presence of functional groups simplifies further modifications of the prepared structures and the design of novel colchicine-derived antitumor compounds with desired pharmacological properties.

2 May 2017 in Synlett
Verified
Journal Article
Closed access
PDF file
SKSergey V. Karpov
Sergey V. Karpov
AGArthur A. Grigor’ev
Arthur A. Grigor’ev
YKYakov S. Kayukov
Yakov S. Kayukov
IGIuliia Gracheva
Iuliia Gracheva
VTVictor A. Tafeenko
Victor A. Tafeenko
2-Acyl-1,1,3,3-tetracyanopropenides (ATCN) undergo cascade heterocyclization under the action of aliphatic thiols, resulting in the formation of 6-(alkylthio)-4-amino-1-aryl(alkyl)-1-hydroxy-3-oxo-2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-7-carbonitriles. The involvement of methyl mercaptoacetate to this reaction leads to the formation of the methyl 4,8-diamino-1-aryl-1-hydroxy-3-oxo-2,3-dihydro-1H-pyrrolo[3,4-d]thieno[2,3-b]pyridine-7-carboxylates, containing a new fused heterocyclic scaffold.